Health-Related Quality of Life Assessment And Communication During 48 Weeks Of Treatment Of Psoriasis Patients With Etanercept.
Phase of Trial: Phase IV
Latest Information Update: 22 Jun 2012
At a glance
- Drugs Etanercept (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- 22 Jun 2012 Actual initiation date (Oct 2008) added as reported by Netherlands Trial Register.
- 22 Jun 2012 Planned end date changed from 30 Sep 2011 to 31 Dec 2012 as reported by Netherlands Trial Register.
- 22 Jun 2012 Status changed from planning to recruiting as reported by Netherlands Trial Register.